Obesity has become a global concern associated with severe health concerns such as heart disease and diabetes. According to the FDA, approximately 70% of American adults are obese or overweight. Health care providers and scientists have been continuously looking for effective, safe ways to help the rising numbers of obesity. Most of the available anti-obesity drugs cause serious side effects limiting their use. However, Semaglitude, a new weight loss drug, has become the game changer in treating obesity and moderate weight loss.
Semaglitude for Weight Loss
Semaglitude is an FDA-approved powerful treatment for chronic weight management issues. Semaglitude is a synthetic form of naturally occurring hormone for metabolism and insulin management. Since 2005, Semaglitude (also known as Wegovy) has been prescribed as an injectable to primarily treat type 2 diabetes by regulating insulin levels in the body. From 2021, the well-researched drug is being used as a safe, effective treatment that consistently enables patients to lose significant weight.
How It Works
The body naturally produces glucagon-like peptide-1 (GLP-1), which regulates appetite centers in the gut and brain, making you feel full. Semaglitude imitates GLP-1, providing similar effects like reducing the feelings of hunger and enabling you to eat less food. Semaglitude is even more effective when combined with exercise, stress-reducing mechanisms such as meditation, breathing exercises, yoga, and a healthy meal plan.
Semaglitude is not a stimulant and does not rely on mechanisms that can harm your overall health, unlike other weight loss medications. Before its approval, the FDA conducted clinical trials which lasted 68 weeks, whereby patients lost an average of 15% of their body weight and 35lb over the trial period. Semaglitude is suitable for adults with:
- Obesity-A body mass index (BMI) of 30kg/m2 or greater
- Overweight- a BMI of 27kg/m2 with weight-related conditions such as type 2 diabetes mellitus or high blood pressure.
Benefits of Semaglitude
Other than weight loss and increased satiety, Semaglitude also improves overall health such as:
- Reduces liver fat
- Improved cardiovascular function
- Decreased arterial stiffness
- Lowers inflammation
- Helps stop smoking
- Treats Polycystic ovary syndrome (PCOS)
- Decreased insulin resistance
- Increased energy levels
Semaglitude is unsuitable for people with the following health conditions:
- Allergic to Semaglitude or any of its ingredients
- Diabetic retinopathy (eye damage)
- Pregnant or trying to get pregnant
- Anyone under 18 years old
- If you have or ever had kidney disease, pancreatitis, or thyroid cancer
- History of suicidal thoughts and depression
Side Effects of Semaglitude
Every medicine has some potential side effects. Most patients have reported some side effects when they start using the medication, which wears off once the body adjusts to Semaglitude. Some side effects are nausea, stomach cramps, vomiting, diarrhea, loss of appetite, and constipation. Report any adverse side effects for your doctor to adjust your dosage.
Semaglitude is first administered with the lowest dosage available; a weekly injection or a daily tablet. The dosage is gradually increased after four weeks until the full dosage is administered (five months), depending on whether or not you have had any side effects. This is called titrating (dose escalation) and is done to reduce the risk of any potential side effects you may experience during treatment. It also helps with gradual weight loss rather than rapidly losing weight. Over time, your body will have new limits to getting full, and avoiding overeating is essential to help maintain the new attained weight.
At Signature Skin Care, we understand that losing weight is not easy. But we can help you achieve your weight loss goals with Semaglitude. Contact us today to know if you are suitable for Semaglitude or to schedule an appointment.